Table 6.
Multivariate analysis by logistic regression for CMV positive in ulcerative colitis
| Index | OR (95% CI) | P |
|---|---|---|
|
CMV DNA |
|
|
| Location |
0.227 (0.093 ~ 0.553) |
0.001* |
| Disease severity |
0.000 (0.000~) |
0.998 |
| Fever |
1.704 (0.357 ~ 8.138) |
0.504 |
| Treatment of corticosteroids |
0.574 (0.228 ~ 1.449) |
0.240 |
| Treatment of ASA/SASP |
1.761 (0.661 ~ 4.691) |
0.258 |
|
CMV IgG |
|
|
| Age |
0.893 (0.398 ~ 2.005) |
0.784 |
| Location |
2.482 (1.145 ~ 5.380) |
0.021* |
| Disease severity |
0.078 (0.009 ~ 0.635) |
0.017* |
| Treatment of ASA/SASP |
0.749 (0.342 ~ 1.639) |
0.470 |
|
CMV IgM |
|
|
| Alb |
0.000 (0.000~) |
0.997 |
| Disease severity |
0.840 (0.000~) |
1.000 |
| Treatment of corticosteroids |
1.038 (0.000~) |
1.000 |
| Treatment of immunodepressant | 0.997 (0.000~) | 0.997 |
CMV, cytomegalovirus; OR, Odds ratio; CI, confidence interval; Alb, albumin; ASA, aminosalicylic acid; SASP, salicylazosulfapyridine.
*indicate significant difference.